Showing results (661-670 of 816) with videos related to

Sort By:
Pageof 82
Steroids|July 17, 2026
Metabolic, hormonal, and inflammatory profiling in lean and obese women with PCOS: A multicentre case-control study in a vegetarian populationForam K Ravat, Sneha M Nair, Mayur Gandhi, et al.
Nanotechnology|August 12, 2011
Mechanism of bright red emission in Si nanoclustersS Dhara, C-Y Lu, K G M Nair, et al.
Analytical and Bioanalytical Chemistry|October 16, 2010
NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppmSarah E Lee, Edward K Chess, Barrett Rabinow, et al.
The Journal of Cardiovascular Nursing|May 27, 2020
Decision Support for Implantable Cardioverter-Defibrillator Replacement: A Pilot Feasibility Randomized Controlled TrialKrystina B Lewis, David Birnie, Sandra L Carroll, et al.
Current Eye Research|December 9, 2022
Using the Chick Embryo Model to Examine the Effects of Hypoxia Pre-conditioning of Uveal Melanoma Cells on Tumor Growth and MetastasisJames Draper, Jodi Alexander, Rohini M Nair, et al.
The Canadian Journal of Cardiology|July 31, 2018
Characterization of Low-Voltage Areas in Patients With Atrial Fibrillation: Insights From High-Density Intracardiac MappingPablo B Nery, Wafa Al Dawood, Girish M Nair, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Relationship Between Pulmonary Vein Reconnection and Atrial Fibrillation Recurrence: A Systematic Review and Meta-AnalysisPablo B Nery, Daniel Belliveau, Girish M Nair, et al.
Marine Pollution Bulletin|February 1, 2021
Distribution, contamination status and bioavailability of trace metals in surface sediments along the southwest coast of IndiaM Cyriac, T R Gireeshkumar, C M Furtado, et al.
Therapeutic Advances in Hematology|November 5, 2024
Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults studyJulie Kanter, Sarah Mennito, Santosh M Nair, et al.
JAMA|February 20, 2014
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trialCarlos A Morillo, Atul Verma, Stuart J Connolly, et al.
Pageof 82